A New Model of Drug Development
We’re bringing cutting-edge research scientists out of their siloed ivory towers and into a new world of collaborative medical research. Why? When researchers share what they know we can make faster progress in our search to find cures for children suffering from infectious diseases in the developing world.
Connect Facebook Twitter Linked InLending scientific expertise to achieve global health
As we address access to medicines and global health advocacy, we rely on our team of scientific advisors. Our advisors are instrumental in developing products that are safe, effective and affordable for the populations we serve. Their expertise in the lab, and in the field help OneWorld Health continue to develop new treatments for those most in need, deliver on the promise of modern medicine accessible to all, and save lives.
Shinjini Bhatnagar, MBBS, DNB (Pediatrics), PhD
Professor, Pediatric Biology Centre, Translational Health Science and Technology Institute (An Autonomous Institute of Dept. of Biotechnology, Min. of Science and Technology, Govt of India)
Zulfiqar Bhutta, MBBS, FRCP, FRCPCH, FCPS, FPAS, PhD
Head, Division of Women and Child Health, Professor, Department of Pediatrics and Child Health, Aga Khan University, Pakistan
Henry J. Binder, MD
Professor of Medicine, Yale University School of Medicine, USA
David Brown, BSc, PhD, FRSC
Consultant, Cambridge, UK
Michael Camilleri, MD
Professor of Medicine and Physiology, Mayo Clinic, Rochester, Minnesota, USA
Mitchell Cohen, MD
Director, Division of Gastroenterology, Hepatology and Nutrition, Vice Chair of Pediatrics for Clinical Affairs, Cincinnati Children's Hospital Medical Center, USA
Manoj Desai, PhD
VP Medicinal Chemistry, Gilead, Inc., USA
Philippe Desjeux, PhD, MD
OneWorld Health Consultant for VL Program, France
Mark Donowitz, MD
LeBoff Professor of Medicine; Director, Hopkins Center for Epithelial Disorders at Johns Hopkins University School of Medicine, USA
Olivier Fontaine, MD, MS, FACP
World Health Organization Director of Diarrheal Diseases, Geneva, Switzerland
M. Scott Harris, MD, MS, FACP, AGAF
Professor of Clinical Medicine, Georgetown University School of Medicine, USA
Clayton Harro, MD, ScM
Director of the Enteric Vaccine Evaluation Unit, Johns Hopkins University Center for Immunization Research, USA
Sharath S. Hegde, PhD
Vice President of Pharmacology at Theravance, USA
Peter Hotez, MD, PhD, FAAP
Distinguished Research Professor and Walter G. Ross Professor and Chair of the Department of Microbiology, Immunology, & Tropical Medicine at The George Washington University. President of the Sabin Vaccine Institute
Patrick P.A. Humphrey, OBE, PhD, DSc, FBPharmacolS(Hon
Consultant, Pharmaceutical R&D, Cambridge, UK
Jennifer Keiser, MD, PhD, MS
Project Leader, Swiss Tropical Institute, Switzerland
David Sack, MD
Professor, Department of International Health, Johns Hopkins Bloomberg School of Public Health, USA
Mohammad Salam, MBBS
Director, Research Administration and Acting Director, Clinical Sciences Division ICDDR,B, Dhaka, Bangladesh
Ann-Mari Svennerholm, MD, PhD
Division of Medicine & Microbiology at Institute of BioMedicine, Sahlgrenska Academy at University of Goteborg, Sweden
Marcel Tanner, Prof. Dr.
Epidemiologist MPH, Director of Swiss TPH, Switzerland
Joaqim Trias, PhD
President, JPTS Consulting, USA
Alan S. Verkman, MD, PhD
Professor, University of California San Francisco School of Medicine, USA